Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies.
about
Genetics and genomics of radiotherapy toxicity: towards predictionExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentEmerging treatment options for nasopharyngeal carcinomaPractice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancerComparing planning time, delivery time and plan quality for IMRT, RapidArc and TomotherapyA national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada.Current role of modern radiotherapy techniques in the management of breast cancerVolumetric modulated arc therapy: a review of current literature and clinical use in practice.Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer.The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Advances in the management of squamous cell carcinoma of the head and neck.Radiation-induced bystander signalling in cancer therapy.Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States.Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancerFactors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada.Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours.Comparison of prostate IMRT and VMAT biologically optimised treatment plans.Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicityInternational Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.Ionizing irradiation protection and mitigation of murine cells by carbamazepine is p53 and autophagy independentEfficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinomaSurveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer.Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT.An update on preoperative radiotherapy for locally advanced rectal cancer.The value of image-guided intensity-modulated radiotherapy in challenging clinical settings.Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancerA novel reduced-order prioritized optimization method for radiation therapy treatment planning.Long-term outcomes of chemoradiation for anal cancer patients.Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.Evaluation of the trade-offs encountered in planning and treating locally advanced head and neck cancer: intensity-modulated radiation therapy vs dual-arc volumetric-modulated arc therapy.Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancerChanging trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States.Whole breast radiotherapy in prone and supine position: is there a place for multi-beam IMRT?High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancer
P2860
Q21183971-9223256E-DDAD-494A-80DD-07119458E698Q26849735-0A61B6F4-63E2-4409-BEFF-FDFC8D7DC314Q26995560-5C85E9F2-4305-446F-A7D9-F66722CEB474Q28252307-652E9B5E-9EBD-43CB-AA90-5A57799BC04BQ28264970-C92CA5AF-466E-451D-A76F-DA7D46A01ECBQ28972349-61A44425-D3E2-4B08-A539-EBA28D08F1E1Q28972351-F0DA9B40-BF2E-46EA-AB5D-266DEE52CED8Q30461426-D4986A87-5095-4EA6-8F79-1D6B97BB7CBAQ30477814-F9483B16-5A6F-4DC5-B783-56E8DAA7697CQ33617669-B65C9EB1-D152-4C67-A435-968503B8C429Q33645619-6824CA10-7BA1-49C9-B529-39F86EA22830Q33720431-44787652-DB03-4EE5-A169-A6220530D587Q33794726-4B92B4E3-9932-4486-8B49-34363A75F853Q33890507-E70D2340-E2BB-4A83-A4B2-932BCF41F608Q33933913-C3C7551F-A758-42E3-B85C-0C4170875DEBQ33975698-7A276E8D-B6D5-45D9-B681-DE7D7C65C1EEQ34008879-A19AD462-D58F-4B96-836F-DA2FB7093D02Q34372750-F4F57647-78FB-4356-BE0F-51B964DF8AD3Q34439277-C15021A1-886E-4494-BA29-2931166D6D6AQ34593033-4919176F-AEAF-4ED0-B1A9-BB44600E078CQ35161100-6684E514-6043-4BFE-B732-1342BFE8941AQ35824278-E3B0688D-301C-4E25-A0E1-45083E67D46EQ35849124-EA3E1105-5CAD-48D5-97AE-D3C5392A8D02Q35870838-A95CA6AA-CD2F-4367-98B0-F2F924EFFE92Q35909071-4DDAF3D9-8D71-470D-94F3-A01590178254Q36051703-EFD71781-897B-43E9-A3F0-FBE275BAC4F0Q36086196-13BD26FA-5723-434C-96ED-14ECCE8DB1F2Q36210612-8B466EC4-033C-4F56-9FC7-1815DC4FD716Q36229969-037F64F1-59AF-4BC5-A263-B57871FC6F93Q36294866-613733FD-EBE9-461C-83A5-886972BED232Q36325935-7721E2B5-EC6D-4BE0-A2F2-8B7DC3B0CAB3Q36357618-08C8BBC8-0509-4F14-A920-7DD7A0C311D3Q36463914-13739DBD-79BE-4A44-93D1-4E814FB379FEQ36720411-31BF6004-58BD-4CF3-8807-08B39A538DEAQ36727093-62812BF6-7B32-4C6E-B8C0-70E8F89FC827Q36765574-693BEEB2-9EF2-4FAC-9D11-780B3C82E0E7Q36944792-32E9A317-2D70-43A0-8A78-C2C4664F0ABEQ36985515-9D991142-7141-4225-9C4C-872874369122Q37037832-6173BDC0-1C25-4241-B1F5-BBE1968C6FD1Q37079068-C9DD23C8-EAA1-49BE-8570-C87E6E978F6D
P2860
Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence behind use of intensi ...... comparative clinical studies.
@en
Evidence behind use of intensi ...... comparative clinical studies.
@nl
type
label
Evidence behind use of intensi ...... comparative clinical studies.
@en
Evidence behind use of intensi ...... comparative clinical studies.
@nl
prefLabel
Evidence behind use of intensi ...... comparative clinical studies.
@en
Evidence behind use of intensi ...... comparative clinical studies.
@nl
P2093
P1433
P1476
Evidence behind use of intensi ...... comparative clinical studies.
@en
P2093
Frank Hulstaert
Gert De Meerleer
Indira Madani
Liv Veldeman
Marc Mareel
Wilfried De Neve
P304
P356
10.1016/S1470-2045(08)70098-6
P577
2008-04-01T00:00:00Z